Cellens
Cambridge, MA · Other · 9 employees
Cellens is a Tufts University spinout startup that is committed to bringing clarity and confidence to patients and physicians through noninvasive cancer detection. We are developing a pipeline of revolutionary noninvasive and accurate at-home and mail-in cancer monitoring tests.
Funding history
- Funding Round — $6.4M — Nov 2025
- Series seed — $585K — Oct 2022
Recent signals
- Nov 14, 2025: Raised $6.4M
- Oct 14, 2022: Raised $585K in Series seed
See plans & pricing → Track Cellens’s funding, hiring, and signals — with verified contacts — on Fundz.